Clinical trial
Pulmonary Hypertension, Hypoxia and Sickle Cell Disease
NCT00495638 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00495638 |
|---|---|
| Title | Pulmonary Hypertension, Hypoxia and Sickle Cell Disease |
| Official title | Pulmonary Hypertension and the Hypoxic Response in SCD |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Chuvash Polycythemia, Cerebrovascular Disease, Pulmonary Hypertension, Sickle Cell Anemia |
| Enrollment | 29 |
| Start date | Jun 28, 2007 |
| Completion | Dec 2, 2014 |
| First posted | Jul 3, 2007 |
| Last update posted | Dec 16, 2019 |
| Countries | Russia, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: